Reteplase biosimilar (Shandong Yuanlong Biotechnology)
瑞替普酶生物类似药（山东元隆生物技术有限公司）
Report date: 2022/02/21 11:11:36
Base Information
Drug NameReteplase biosimilar (Shandong Yuanlong Biotechnology)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (IND)
Highest Status in ChinaPending
Originator CompaniesShandong Yuanlong Biotechnology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesShandong Yuanlong Biotechnology Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC Code
Related LinksN/A